| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |